Directory

>

Miri Halperin Wernli

Miri Halperin Wernli

Executive President | MindMed

Zug, Zug, Switzerland

View contact details (it's free)

Miri Halperin Wernli

Summary

Miri Halperin Wernli is a seasoned executive in the pharmaceutical industry, currently serving as the Executive President of MindMed Inc., a company focused on innovative treatments for brain health disorders. With a strong background in biomedical research, clinical development, and general management, Miri has led significant initiatives in global clinical operations and portfolio management. Her previous roles include co-founding Creso Pharma, where she played a pivotal role in cannabis innovation, and serving as Vice President at Actelion Pharmaceuticals, overseeing global clinical development. Miri holds an Executive MBA from Stanford University and a doctorate in Genetics and Experimental Psychology from the University of Geneva. She is passionate about advancing healthcare solutions that enhance patient outcomes and has a wealth of experience in both startup and corporate environments. Miri's leadership style is characterized by a deep commitment to scientific integrity and innovation.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Miri Halperin Wernli

Work Experience

company logo

Executive President at

MindMed

August 2020 - Present

company logo

Board Member at

Creso Pharma

August 2020 - March 2021

company logo

Co-Founder, Group Chief Executive Officer and Executive Director at

Creso Pharma

July 2016 - August 2020

company logo

Vice President, Deputy Head Gobal Clinical Development, Global Head Business & Science Affairs at

Actelion (now Janssen Pulmonary Hypertension)

September 2001 - June 2016

Logos provided by Logo.dev

Miri Halperin Wernli

Education

Stanford Graduate School of Business, Executive Mba

January 1997 - January 1998

University of Geneva, Dr.

January 1974 - January 1984

Frequently Asked Questions about Miri Halperin Wernli

What is Miri Halperin Wernli email address?

Miri Halperin Wernli's primary email address is ***************@mindmed.co. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Miri Halperin Wernli work for?

Miri Halperin Wernli is a Executive President at MindMed, a company specializing in Commercial physical research.

Where Miri Halperin Wernli graduated from?

Miri Halperin Wernli holds a degree in from Stanford Graduate School of Business.

How can I directly contact Miri Halperin Wernli?

To contact Miri Halperin Wernli directly, you can use the email address ***************@mindmed.co. Complete contact information is available upon registration with Muraena.

Who is Miri Halperin Wernli?

Miri Halperin Wernli is a seasoned executive in the pharmaceutical industry, currently serving as the Executive President of MindMed Inc., a company focused on innovative treatments for brain health disorders. With a strong background in biomedical research, clinical development, and general management, Miri has led significant initiatives in global clinical operations and portfolio management. Her previous roles include co-founding Creso Pharma, where she played a pivotal role in cannabis innovation, and serving as Vice President at Actelion Pharmaceuticals, overseeing global clinical development. Miri holds an Executive MBA from Stanford University and a doctorate in Genetics and Experimental Psychology from the University of Geneva. She is passionate about advancing healthcare solutions that enhance patient outcomes and has a wealth of experience in both startup and corporate environments. Miri's leadership style is characterized by a deep commitment to scientific integrity and innovation.

Miri`s contact details

mail

***************@mindmed.co

Colleagues

avatar
Suzanne Bruhn

Chief Executive Officer

avatar
Paula Jacobsen

Executive Director, Global Clinical Development

avatar
Peter Mack

VP of Pharmaceutical Development

avatar
Robert Barrow

Chief Executive Officer

avatar
Carrie Liao Cpa Cgma

Chief Accounting Officer

avatar
Francois Lilienthal Md

Chief Commercial Officer (CCO)

avatar
Jamie F

Executive Director, Head Of Clinical Operations

Carole Abel

VP of Programs and Portfolio Office and Program Leader

avatar
Michael Seggev

Vice President, Global Marketing, Strategic Insights & Digital Innovation

View Contact details (it's free)
Request Profile Removal